Tirzepatide 15mg: reaching the highest licensed dose

Step 1: Why 15mg is the end point, not the starting point

The dose ladder for tirzepatide exists for a practical reason: starting at the highest available dose would cause significant nausea for most people. The 2.5mg starter pen is there to let your digestive system adjust, not to produce weight loss on its own. From there, titration moves upward roughly every four weeks (5mg, 7.5mg, 10mg, 12.5mg) until 15mg is reached, if that is what your prescriber decides is right.

For many people, the titration itself takes five months or more. Timing matters in everyday life: if you start treatment on a 12-week supply and a bank holiday falls across your usual delivery window, it is worth planning repeat orders ahead of time so a gap does not disrupt your schedule. Our frequently asked questions covers repeat ordering in more detail.

The key point is that 15mg is a target, not an entitlement. Some people find a lower dose produces excellent results and tolerate it far better. The decision rests with your prescriber, who reviews your progress at each stage. You can read a broader overview of how tirzepatide works across all doses if you want more context on the mechanism before focusing on this specific strength.

Step 2: What the trial evidence actually shows at this dose

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity but without type 2 diabetes across three dose groups and placebo. At 15mg, average body-weight reduction was around 20–21% over 72 weeks, with some analyses reaching approximately 22.5% for participants who stayed on treatment throughout. To put that concretely: for someone starting at 100kg, that translates to roughly 20–22kg lost on average.

Those figures come from a controlled trial setting, with lifestyle support provided alongside medication. Real-world results vary. Age, starting weight, activity levels, diet and how well each dose is tolerated all play a role. The trial results represent what is possible, not what is promised. Mounjaro 15mg covers the UK-branded version of this dose in more detail if you are searching for that specific product name.

For comparison, the SURMOUNT-5 trial, published in 2025, found tirzepatide produced a greater average weight reduction than semaglutide 2.4mg in a head-to-head over 72 weeks, a result referenced by NICE in their appraisal TA1026, which recommends tirzepatide for eligible adults in England. That does not make tirzepatide the right choice for everyone; the clinical picture always matters more than a headline comparison.

Step 3: Side effects at higher doses and what to watch for

Gastrointestinal effects are the most commonly reported: nausea, loose stools, constipation, indigestion, burping and fatigue. At 15mg, these tend to be more pronounced than at lower strengths, particularly in the first few weeks after stepping up. For many people they settle within a fortnight. Eating smaller meals, avoiding high-fat or rich foods in the short term, and staying well hydrated helps significantly.

The NHS patient information for tirzepatide sets out the full side-effect profile. The signs that need prompt medical attention are worth knowing: severe stomach pain that radiates to the back can indicate pancreatitis and needs same-day assessment. Gallbladder symptoms (sharp pain under the right ribs, especially after eating) also warrant a call to your GP or 111 rather than waiting. Suspected side effects can be reported directly via the MHRA's Yellow Card scheme.

This is not a reason to avoid the highest dose; it is a reason to titrate carefully and to keep your clinical team informed. Women taking the oral contraceptive pill should add a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the slowing of gastric emptying can reduce pill absorption. Our clinical team addresses exactly these questions during consultation.

Step 4: Private access and what a realistic cost picture looks like

Tirzepatide is available on the NHS, but the current eligibility criteria are strict and phased: as of mid-2026, NHS access broadly requires a BMI of 35 or above alongside several weight-related conditions, accessed through an approved pathway. Most people searching for tirzepatide 15mg privately do so because they do not yet qualify for NHS supply or prefer not to wait. If you are curious about how tirzepatide l fits into the broader range of available options, that page gives a useful point of comparison. For a fuller picture of Mounjaro pricing in the UK, that page explains what the private market looks like following Eli Lilly's list-price increase in September 2025.

Private treatment through a regulated pharmacy requires a prescription following clinical assessment, not a workaround, just the legal route. When you order through a GPhC-registered online pharmacy, your consultation is reviewed by a real prescriber. At nume, that review happens the same day. You can explore our weight-loss treatments to see what a consultation involves, and if you are weighing up different GLP-1 options, this comparison page explains how the UK brand name and generic name relate to each other.

One thing worth knowing before you start: supply at the highest doses has occasionally been constrained. If you are currently at a lower strength and considering whether 15mg is your next step, you may find it helpful to read about tirzepatide 30 so you have a clear picture of the full dose range before discussing your plan with your prescriber. The weight-loss overview explains how lifestyle support fits alongside whichever dose you end up on.